Home Cart 0 Sign in  
X

[ CAS No. 456-06-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 456-06-4
Chemical Structure| 456-06-4
Chemical Structure| 456-06-4
Structure of 456-06-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 456-06-4 ]

Related Doc. of [ 456-06-4 ]

Alternatived Products of [ 456-06-4 ]

Product Details of [ 456-06-4 ]

CAS No. :456-06-4 MDL No. :MFCD00060562
Formula : C7H7FN2O Boiling Point : -
Linear Structure Formula :- InChI Key :UIVXXFYJRYVRKJ-UHFFFAOYSA-N
M.W : 154.14 Pubchem ID :9972
Synonyms :

Calculated chemistry of [ 456-06-4 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 37.3
TPSA : 55.12 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.22 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.09
Log Po/w (XLOGP3) : 0.03
Log Po/w (WLOGP) : 0.85
Log Po/w (MLOGP) : 1.56
Log Po/w (SILICOS-IT) : 0.62
Consensus Log Po/w : 0.83

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.09
Solubility : 12.6 mg/ml ; 0.082 mol/l
Class : Very soluble
Log S (Ali) : -0.74
Solubility : 28.1 mg/ml ; 0.182 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.3
Solubility : 0.769 mg/ml ; 0.00499 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.08

Safety of [ 456-06-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 456-06-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 456-06-4 ]
  • Downstream synthetic route of [ 456-06-4 ]

[ 456-06-4 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 451-46-7 ]
  • [ 456-06-4 ]
YieldReaction ConditionsOperation in experiment
100% With hydrazine hydrate In ethanol at 20 - 85℃; for 10 h; Reflux To a stirred solution of 4-flouroethylbenzoate (4.5 g, 26.7 mmol) in EtOH (30 mL) was added NH2NH2.H20 (6.67 g, 133.5 mmol) at room temperature and the solution refluxed at 85°C for 10 h. The reaction was cooled to room temperature, concentrated under reduced pressure, and the solid washed with n-hexane (50 mL) and then dried to obtain 4-fluorobenzohydrazide as a solid (4.2 g, quantitative yield). 1H NMR (400 MHz, DMSO-d6): δ 9.85 (s, 1H), 7.86 (dd, 2H), 7.25 (t, 3H), 4.46 (s, 1H), 3.47 (br s, 1H).
97% With hydrazine hydrate In ethanol; waterReflux General procedure: Hydrazides (30–58) were synthesized by one pot conventionalmethod24 Benzoic acid or its derivative (10 mmol) was dissolvedin ethanol (20 mL). Sulfuric acid (3 N, 2 mL) was added and thereaction contents were refluxed for six hours. The reaction wasmonitored with TLC. After the completion of the reaction, the reactionmixture was neutralized by adding solid NaHCO3, and filteredto remove excess of NaHCO3. In the neutralized reaction mixture which contains ethyl ester, hydrazine monohydrate (1.5 mL,3 mmol) was added and refluxed for 3–6 h to complete the reaction.Ethanol and unreacted hydrazine were removed by distillationupto 1/3 volume. The reaction contents were cooled, filteredand recrystallized from methanol to obtain the desired hydrazidecrystals (see Supporting information).
83% With hydrazine hydrate In ethanol at 80℃; for 4 h; First, 10 g of 4-fluoroethyl benzoate and 30 mL of ethanol were put in a 100 mL three-neck flask, and stirred. Then, 10 mL of hydrazine monohydrate was added to this mixed solution, and heated and stirred at 80 °C for 4 hours to be reacted. The reaction mixture was added to 100 mL of water, and a solid was precipitated. This solid was subjected to suction filtration and washed with a mixed solvent of ethanol and hexane, so that 4-fluorobenzoylhydrazine was prepared (a white solid, yield: 83 percent). The synthetic scheme of Step 1 is shown by (a-2).
57% With hydrazine hydrate In ethanol at 80℃; for 6 h; First, 25 g of 4-fluoroethyl benzoate and 100 mL of ethanol were put in a 500 mL three-neck flask and stirred. Then, 20 mL of hydrazine monohydrate was added to this mixed solution, and heated and stirred at 80° C. for 6 hours. After the stirring, the reacted mixture was added to 250 mL of water, and a white solid was precipitated. Ethyl acetate was added to this mixture, and the solid was dissolved. An organic layer and an aqueous layer were separated, and the aqueous layer was extracted with ethyl acetate. The resulting extract and organic layer were together washed with a saturated aqueous sodium chloride solution, and then anhydrous magnesium sulfate was added to the organic layer for drying. After the drying, this mixture was subjected to gravity filtration, and the resulting filtrate was concentrated to give a white solid. The given white solid was washed with hexane, so that 4-fluorobenzoylhydrazine was prepared (a white solid, yield: 57percent).

Reference: [1] Patent: WO2013/49559, 2013, A1, . Location in patent: Page/Page column 92
[2] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 17, p. 6014 - 6024
[3] Patent: WO2011/52516, 2011, A1, . Location in patent: Page/Page column 59
[4] Journal of Nanoscience and Nanotechnology, 2013, vol. 13, # 5, p. 3321 - 3330
[5] European Journal of Medicinal Chemistry, 2010, vol. 45, # 9, p. 3943 - 3949
[6] European Journal of Medicinal Chemistry, 2010, vol. 45, # 9, p. 3960 - 3969
[7] Journal of Labelled Compounds and Radiopharmaceuticals, 2006, vol. 49, # 2, p. 125 - 137
[8] Patent: JP5787538, 2015, B2, . Location in patent: Paragraph 0161; 0162
[9] Journal of the American Chemical Society, 1950, vol. 72, p. 1806
[10] Journal of Medicinal Chemistry, 2003, vol. 46, # 16, p. 3463 - 3475
[11] Journal of Agricultural and Food Chemistry, 2003, vol. 51, # 1, p. 152 - 155
[12] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 8, p. 2278 - 2282
[13] Tetrahedron, 2008, vol. 64, # 8, p. 1860 - 1867
[14] European Journal of Medicinal Chemistry, 2009, vol. 44, # 5, p. 2113 - 2121
[15] European Journal of Medicinal Chemistry, 2009, vol. 44, # 9, p. 3798 - 3804
[16] Journal of Medicinal Chemistry, 2009, vol. 52, # 14, p. 4200 - 4209
[17] Journal of Chemical Research, 2010, # 7, p. 410 - 413
[18] Journal of Medicinal Chemistry, 2010, vol. 53, # 20, p. 7392 - 7404
[19] Bioorganic and Medicinal Chemistry, 2010, vol. 18, # 22, p. 7836 - 7841
[20] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 2, p. 332 - 335
[21] Journal of Chemical Research, 2010, vol. 34, # 12, p. 680 - 683
[22] Journal of Chemical Research, 2011, vol. 35, # 4, p. 234 - 237
[23] Journal of Chemical Research, 2011, vol. 35, # 6, p. 364 - 367
[24] Medicinal Chemistry Research, 2012, vol. 21, # 11, p. 3646 - 3655
[25] Organic Preparations and Procedures International, 2017, vol. 49, # 4, p. 370 - 376
[26] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 8, p. 2286 - 2297
[27] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 22, p. 5154 - 5156
[28] Journal of the Chemical Society of Pakistan, 2013, vol. 35, # 3, p. 929 - 937
[29] Medicinal Chemistry Research, 2013, vol. 22, # 11, p. 5344 - 5348
[30] Journal of Chemical Research, 2014, vol. 38, # 5, p. 300 - 303
[31] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 15, p. 3052 - 3056
[32] Journal of Heterocyclic Chemistry, 2015, vol. 52, # 5, p. 1296 - 1301
[33] Journal of Heterocyclic Chemistry, 2017, vol. 54, # 2, p. 1423 - 1429
[34] Asian Journal of Chemistry, 2015, vol. 27, # 10, p. 3605 - 3608
[35] Asian Journal of Chemistry, 2016, vol. 28, # 3, p. 639 - 643
[36] Bioorganic Chemistry, 2016, vol. 65, p. 126 - 136
[37] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 8, p. 1879 - 1888
[38] Patent: WO2016/108249, 2016, A1, . Location in patent: Paragraph 053
[39] Journal of the Brazilian Chemical Society, 2016, vol. 27, # 11, p. 1998 - 2010
[40] Chemical Biology and Drug Design, 2017, vol. 90, # 2, p. 236 - 243
[41] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 20, p. 5652 - 5661
[42] Chinese Journal of Chemistry, 2017, vol. 35, # 9, p. 1437 - 144
[43] Oriental Journal of Chemistry, 2017, vol. 33, # 6, p. 2930 - 2936
[44] RSC Advances, 2018, vol. 8, # 12, p. 6306 - 6314
[45] Patent: CN108218848, 2018, A, . Location in patent: Paragraph 0152; 0153; 0155
[46] Patent: CN104892639, 2018, B, . Location in patent: Paragraph 0065
  • 2
  • [ 403-33-8 ]
  • [ 456-06-4 ]
YieldReaction ConditionsOperation in experiment
83% With hydrazine hydrate In methanol for 5 h; Reflux General procedure: To a solution of an appropriate methyl esters17(a–j) (1.0 mmol) in 50 mL of methanol was added 99 percenthydrazine hydrate (4.0 mmol) and the mixture was refluxedfor 5 h up to reaction completed (TLC). After completionof reaction, it was allowed to cool and the obtained solidwas washed with methanol. The crude products wererecrystallized from ethanol.
80% With hydrazine hydrate In ethanol at 40℃; General procedure: Various methyl benzoate 8A-V (1.0 equiv) reacted with hydrazine hydrate (excess amount) in anhydrous ethanol. The reaction was stirred at 40 °C for overnight. The ethanol was removed under reduced pressure. The products were purified by recrystallization, which were washed with ethyl ether. The products were obtained as white solid.
75% With hydrazine hydrate In ethanol for 5 h; Reflux General procedure: Compound 12 (0.013 mol) and 80percent NH2NH2H2O (5 mL) wereadded to EtOH (10 mL), the mixturewas stirred under reflux for 5 h.After being cooled to room temperature, the precipitate was obtainedby filtration, and was dried to give the title compounds,respectively.4.1.7.1. 4-Fluorobenzohydrazide (13a). A white solid. Yield: 75percent. Mp161.9e164.4 C. 1H NMR (400 MHz, DMSO-d6) d 9.78 (s, 1H,eNHeN), 7.83e7.93 (m, 2H, ArH), 7.22e7.33 (m, 2H, ArH), 4.48 (s,2H, eNHeNH2). ESI-MS m/z: 155.1 [M H].
50% With hydrazine hydrate In ethanol for 24 h; Reflux General procedure: Various benzohydrazides 5-7 and 9-13 were obtained accordingto known procedures [40,65] except for benzohydrazides 4and 8 which were commercially available. A solution of the methylbenzoate (1 equiv) in ethanol was added dropwise to 65percent hydrazinemonohydrate (5 equiv). The reaction mixture was then heatedunder reflux and stirred overnight. The reaction progress was followedup by TLC. Crude product was collected by filtration aftercooling of the reaction medium and finally washed with coldethanol unless specified otherwise. The desired benzohydrazides were used without any further purification.The analysis of spectral data (1H and 13C NMR), the yields, HRMS,Mp and Rf of these precursors are presented in SupplementaryInformation.
280 mg Reflux General procedure: 4-fluorobenzoic acid as the raw material, methanol as a reaction solvent, a small amount of concentrated sulfuric acid catalyst, followed by stirring under heating at reflux, thin layer chromatography (TLC) to track progress of the reaction, a certain amount after the completion of the reaction NaHCO3Solution for hydrazine and the reaction liquid solution to give ester intermediate (3-1), continue to add more than the corresponding proportion of hydrazine hydrate reaction mixture was heated with stirring at reflux, thin layer chromatography (TLC) to track progress of the reaction, the reaction after completion of the reaction solution was added to a certain amount of water, then a large amount of white sink to the bottom, suction filtration to afford intermediate hydrazides (3-2)

Reference: [1] Biomedicine and Pharmacotherapy, 2017, vol. 94, p. 499 - 513
[2] Letters in Drug Design and Discovery, 2012, vol. 9, # 3, p. 276 - 281
[3] Medicinal Chemistry Research, 2016, vol. 25, # 4, p. 627 - 643
[4] European Journal of Medicinal Chemistry, 2016, vol. 120, p. 202 - 216
[5] New Journal of Chemistry, 2016, vol. 40, # 10, p. 8846 - 8854
[6] European Journal of Medicinal Chemistry, 2015, vol. 104, p. 115 - 126
[7] Arzneimittel-Forschung/Drug Research, 2001, vol. 51, # 7, p. 569 - 573
[8] European Journal of Medicinal Chemistry, 2018, vol. 159, p. 324 - 338
[9] Journal of the Indian Chemical Society, 1982, vol. 59, # 10, p. 1174 - 1176
[10] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 8, p. 3028 - 3036
[11] Zeitschrift fur Naturforschung - Section B Journal of Chemical Sciences, 2010, vol. 65, # 2, p. 178 - 184
[12] Monatshefte fur Chemie, 2010, vol. 141, # 4, p. 479 - 484
[13] Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2011, vol. 79, # 5, p. 1837 - 1842
[14] Journal of Molecular Structure, 2011, vol. 1003, # 1-3, p. 52 - 61
[15] Magnetic Resonance in Chemistry, 2011, vol. 49, # 10, p. 648 - 654
[16] Journal of Molecular Structure, 2012, vol. 1011, p. 121 - 127
[17] Journal of Agricultural and Food Chemistry, 2012, vol. 60, # 4, p. 1036 - 1041
[18] Medicinal Chemistry, 2012, vol. 8, # 6, p. 1190 - 1197,8
[19] Medicinal Chemistry, 2012, vol. 8, # 6, p. 1190 - 1197
[20] Zeitschrift fur Naturforschung - Section B Journal of Chemical Sciences, 2015, vol. 70, # 8, p. 609 - 616
[21] Medicinal Chemistry Research, 2013, vol. 22, # 3, p. 1305 - 1312
[22] Medicinal Chemistry Research, 2013, vol. 22, # 10, p. 4980 - 4991
[23] Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2013, vol. 115, p. 683 - 689
[24] Chemical Biology and Drug Design, 2013, vol. 82, # 5, p. 546 - 556
[25] Comptes Rendus Chimie, 2015, vol. 18, # 12, p. 1320 - 1327
[26] Phosphorus, Sulfur and Silicon and the Related Elements, 2016, vol. 191, # 6, p. 904 - 907
[27] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 1, p. 192 - 194
[28] Medicinal Chemistry Research, 2014, vol. 23, # 4, p. 1661 - 1671
[29] Synthetic Communications, 2014, vol. 44, # 18, p. 2724 - 2737
[30] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 3, p. 481 - 484
[31] Chemical Communications, 2015, vol. 51, # 76, p. 14365 - 14368
[32] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 21, p. 5611 - 5617
[33] Letters in Drug Design and Discovery, 2016, vol. 13, # 9, p. 968 - 981
[34] Journal of the Chemical Society of Pakistan, 2016, vol. 38, # 5, p. 864 - 881
[35] Patent: CN104488911, 2016, B, . Location in patent: Paragraph 0019-0020
[36] Patent: CN104488908, 2016, B, . Location in patent: Paragraph 0007; 0016; 0017
[37] Patent: CN104488909, 2016, B, . Location in patent: Paragraph 0016-0017
[38] Patent: CN104522035, 2016, B, . Location in patent: Paragraph 0016; 0017
[39] Patent: CN104542624, 2016, B, . Location in patent: Paragraph 0019; 0020
[40] Patent: CN104521990, 2016, B, . Location in patent: Paragraph 0016; 0017
[41] Chemical Biology and Drug Design, 2017, vol. 90, # 2, p. 200 - 209
[42] Patent: CN104672162, 2017, B, . Location in patent: Paragraph 0111; 0112
[43] Patent: CN104488963, 2017, B, . Location in patent: Paragraph 0026-0027
[44] Patent: CN106957242, 2017, A, . Location in patent: Paragraph 0085; 0087; 0088; 0089; 0091
[45] Patent: CN106866708, 2017, A, . Location in patent: Paragraph 0080
[46] Patent: CN104488893, 2017, B, . Location in patent: Paragraph 0036; 0037
[47] Patent: CN104488900, 2017, B, . Location in patent: Paragraph 0007; 0016-0017
[48] Patent: CN104488926, 2016, B, . Location in patent: Page/Page column 0016; 0018
[49] Bulletin of the Chemical Society of Ethiopia, 2017, vol. 31, # 3, p. 481 - 489
[50] Pharmaceutical Chemistry Journal, 2018, vol. 51, # 10, p. 907 - 917
[51] Journal of Chemistry, 2017, vol. 2017,
  • 3
  • [ 2714-90-1 ]
  • [ 456-06-4 ]
Reference: [1] Farmaco, 1997, vol. 52, # 11, p. 691 - 695
[2] Journal of Medicinal Chemistry, 2004, vol. 47, # 27, p. 6760 - 6767
[3] European Journal of Medicinal Chemistry, 2006, vol. 41, # 11, p. 1253 - 1261
[4] European Journal of Medicinal Chemistry, 2016, vol. 124, p. 270 - 283
  • 4
  • [ 456-22-4 ]
  • [ 456-06-4 ]
Reference: [1] European Journal of Medicinal Chemistry, 2017, vol. 138, p. 396 - 406
[2] Journal of Chemical Research - Part S, 2003, # 12, p. 768 - 769
[3] Heterocyclic Communications, 2002, vol. 8, # 6, p. 601 - 606
[4] Journal of Labelled Compounds and Radiopharmaceuticals, 2006, vol. 49, # 2, p. 125 - 137
[5] Journal of Chemical Research, 2010, vol. 34, # 12, p. 680 - 683
[6] Journal of Chemical Research, 2011, vol. 35, # 4, p. 234 - 237
[7] Monatshefte fur Chemie, 2010, vol. 141, # 4, p. 479 - 484
[8] Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2011, vol. 79, # 5, p. 1837 - 1842
[9] Journal of Chemical Research, 2011, vol. 35, # 6, p. 364 - 367
[10] Journal of Molecular Structure, 2011, vol. 1003, # 1-3, p. 52 - 61
[11] Journal of Molecular Structure, 2012, vol. 1011, p. 121 - 127
[12] Journal of Agricultural and Food Chemistry, 2012, vol. 60, # 4, p. 1036 - 1041
[13] Letters in Drug Design and Discovery, 2012, vol. 9, # 3, p. 276 - 281
[14] Medicinal Chemistry, 2012, vol. 8, # 6, p. 1190 - 1197,8
[15] Medicinal Chemistry, 2012, vol. 8, # 6, p. 1190 - 1197
[16] Medicinal Chemistry Research, 2012, vol. 21, # 11, p. 3646 - 3655
[17] Medicinal Chemistry Research, 2013, vol. 22, # 3, p. 1305 - 1312
[18] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 8, p. 2286 - 2297
[19] Medicinal Chemistry Research, 2013, vol. 22, # 11, p. 5344 - 5348
[20] Chemical Biology and Drug Design, 2013, vol. 82, # 5, p. 546 - 556
[21] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 1, p. 192 - 194
[22] Journal of the Brazilian Chemical Society, 2014, vol. 25, # 1, p. 104 - 111
[23] Journal of Chemical Research, 2014, vol. 38, # 5, p. 300 - 303
[24] Medicinal Chemistry Research, 2014, vol. 23, # 4, p. 1661 - 1671
[25] Synthetic Communications, 2014, vol. 44, # 18, p. 2724 - 2737
[26] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 22, p. 5154 - 5156
[27] Journal of the Chemical Society of Pakistan, 2014, vol. 36, # 5, p. 852 - 857
[28] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 15, p. 3052 - 3056
[29] Chemical Communications, 2015, vol. 51, # 76, p. 14365 - 14368
[30] Journal of Heterocyclic Chemistry, 2015, vol. 52, # 5, p. 1296 - 1301
[31] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 17, p. 6014 - 6024
[32] Comptes Rendus Chimie, 2015, vol. 18, # 12, p. 1320 - 1327
[33] Phosphorus, Sulfur and Silicon and the Related Elements, 2016, vol. 191, # 6, p. 904 - 907
[34] RSC Advances, 2015, vol. 5, # 118, p. 97089 - 97101
[35] Asian Journal of Chemistry, 2015, vol. 27, # 10, p. 3605 - 3608
[36] Asian Journal of Chemistry, 2016, vol. 28, # 3, p. 639 - 643
[37] Zeitschrift fur Naturforschung - Section B Journal of Chemical Sciences, 2015, vol. 70, # 8, p. 609 - 616
[38] Bioorganic Chemistry, 2016, vol. 65, p. 126 - 136
[39] Medicinal Chemistry Research, 2016, vol. 25, # 4, p. 627 - 643
[40] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 21, p. 5611 - 5617
[41] Journal of the Brazilian Chemical Society, 2016, vol. 27, # 11, p. 1998 - 2010
[42] Letters in Drug Design and Discovery, 2016, vol. 13, # 9, p. 968 - 981
[43] Journal of the Chemical Society of Pakistan, 2016, vol. 38, # 5, p. 864 - 881
[44] Chinese Journal of Chemistry, 2016, vol. 34, # 12, p. 1236 - 1244
[45] Journal of Heterocyclic Chemistry, 2017, vol. 54, # 2, p. 1423 - 1429
[46] Chemical Biology and Drug Design, 2017, vol. 90, # 2, p. 236 - 243
[47] Patent: CN104672162, 2017, B,
[48] Biomedicine and Pharmacotherapy, 2017, vol. 94, p. 499 - 513
[49] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 20, p. 5652 - 5661
[50] Oriental Journal of Chemistry, 2017, vol. 33, # 6, p. 2930 - 2936
[51] Pharmaceutical Chemistry Journal, 2018, vol. 51, # 10, p. 907 - 917
[52] RSC Advances, 2018, vol. 8, # 12, p. 6306 - 6314
[53] Journal of Chemistry, 2017, vol. 2017,
[54] Patent: CN108218848, 2018, A,
  • 5
  • [ 403-43-0 ]
  • [ 456-06-4 ]
Reference: [1] European Journal of Medicinal Chemistry, 2006, vol. 41, # 11, p. 1253 - 1261
[2] Journal of Medicinal Chemistry, 2004, vol. 47, # 27, p. 6760 - 6767
[3] Farmaco, 1997, vol. 52, # 11, p. 691 - 695
[4] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 1, p. 192 - 194
[5] Journal of Chemical Research, 2014, vol. 38, # 5, p. 300 - 303
[6] Chemistry - A European Journal, 2015, vol. 21, # 26, p. 9550 - 9555
[7] RSC Advances, 2015, vol. 5, # 80, p. 65351 - 65357
[8] European Journal of Medicinal Chemistry, 2016, vol. 124, p. 270 - 283
  • 6
  • [ 90172-63-7 ]
  • [ 456-06-4 ]
Reference: [1] RSC Advances, 2015, vol. 5, # 118, p. 97089 - 97101
  • 7
  • [ 460-00-4 ]
  • [ 456-06-4 ]
Reference: [1] Chemistry - A European Journal, 2015, vol. 21, # 26, p. 9550 - 9555
  • 8
  • [ 459-57-4 ]
  • [ 456-06-4 ]
Reference: [1] New Journal of Chemistry, 2016, vol. 40, # 10, p. 8846 - 8854
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 456-06-4 ]

Fluorinated Building Blocks

Chemical Structure| 446-24-2

[ 446-24-2 ]

2-Fluorobenzohydrazide

Similarity: 0.91

Chemical Structure| 824-75-9

[ 824-75-9 ]

4-Fluorobenzamide

Similarity: 0.90

Chemical Structure| 455-37-8

[ 455-37-8 ]

3-Fluorobenzamide

Similarity: 0.88

Chemical Structure| 445-28-3

[ 445-28-3 ]

2-Fluorobenzamide

Similarity: 0.81

Chemical Structure| 886502-14-3

[ 886502-14-3 ]

2-Fluoro-6-methylbenzamide

Similarity: 0.81

Aryls

Chemical Structure| 446-24-2

[ 446-24-2 ]

2-Fluorobenzohydrazide

Similarity: 0.91

Chemical Structure| 824-75-9

[ 824-75-9 ]

4-Fluorobenzamide

Similarity: 0.90

Chemical Structure| 455-37-8

[ 455-37-8 ]

3-Fluorobenzamide

Similarity: 0.88

Chemical Structure| 445-28-3

[ 445-28-3 ]

2-Fluorobenzamide

Similarity: 0.81

Chemical Structure| 886502-14-3

[ 886502-14-3 ]

2-Fluoro-6-methylbenzamide

Similarity: 0.81

Amides

Chemical Structure| 446-24-2

[ 446-24-2 ]

2-Fluorobenzohydrazide

Similarity: 0.91

Chemical Structure| 824-75-9

[ 824-75-9 ]

4-Fluorobenzamide

Similarity: 0.90

Chemical Structure| 455-37-8

[ 455-37-8 ]

3-Fluorobenzamide

Similarity: 0.88

Chemical Structure| 445-28-3

[ 445-28-3 ]

2-Fluorobenzamide

Similarity: 0.81

Chemical Structure| 886502-14-3

[ 886502-14-3 ]

2-Fluoro-6-methylbenzamide

Similarity: 0.81

Hydrazides

Chemical Structure| 446-24-2

[ 446-24-2 ]

2-Fluorobenzohydrazide

Similarity: 0.91

Chemical Structure| 34547-28-9

[ 34547-28-9 ]

2-(4-Fluorophenyl)acetohydrazide

Similarity: 0.81

Chemical Structure| 2760-98-7

[ 2760-98-7 ]

Isophthalic dihydrazide

Similarity: 0.79

Chemical Structure| 613-94-5

[ 613-94-5 ]

Benzohydrazide

Similarity: 0.79

Chemical Structure| 1016768-00-5

[ 1016768-00-5 ]

4-Chloro-2-fluorobenzohydrazide

Similarity: 0.74

Amines

Chemical Structure| 446-24-2

[ 446-24-2 ]

2-Fluorobenzohydrazide

Similarity: 0.91

Chemical Structure| 824-75-9

[ 824-75-9 ]

4-Fluorobenzamide

Similarity: 0.90

Chemical Structure| 455-37-8

[ 455-37-8 ]

3-Fluorobenzamide

Similarity: 0.88

Chemical Structure| 445-28-3

[ 445-28-3 ]

2-Fluorobenzamide

Similarity: 0.81

Chemical Structure| 886502-14-3

[ 886502-14-3 ]

2-Fluoro-6-methylbenzamide

Similarity: 0.81

Hydrazines

Chemical Structure| 446-24-2

[ 446-24-2 ]

2-Fluorobenzohydrazide

Similarity: 0.91

Chemical Structure| 34547-28-9

[ 34547-28-9 ]

2-(4-Fluorophenyl)acetohydrazide

Similarity: 0.81

Chemical Structure| 2760-98-7

[ 2760-98-7 ]

Isophthalic dihydrazide

Similarity: 0.79

Chemical Structure| 613-94-5

[ 613-94-5 ]

Benzohydrazide

Similarity: 0.79

Chemical Structure| 1016768-00-5

[ 1016768-00-5 ]

4-Chloro-2-fluorobenzohydrazide

Similarity: 0.74